George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.27
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.27
CLLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

16 May 2017 11:47

RNS Number : 3000F
Carillion PLC
16 May 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Carillion Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

3. Full name of person(s) subject to thenotification obligation: iii

Citigroup Global Markets Limited

4. Full name of shareholder(s)  (if different from 3.):iv

N/A

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

12-May-2017

6. Date on which issuer notified:

16-May-2017

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB0007365546

21,336,535

21,336,535

5,702,793

5,702,793

0

1.3254%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

Right to recall lent securities

50,000

0.0116%

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

Equity Swap

-

 

11/03/2017

08/28/2017

08/28/2017

11/07/2017

01/09/2018

01/18/2018

05/29/2018

11/03/2017

 

11/03/2017

11/03/2017

05/29/2018

10/11/2018

10/11/2018

09/06/2017

09/19/2017

17,302,066

4.0214%

Total (A+B+C)

Number of voting rights

Percentage of voting rights

23,054,859

5.3584%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Connor McLaughlin

15. Contact telephone number:

+44 2895 955328

Connor.mclaughlin@citi.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFSIEFIRLID
Date   Source Headline
13th Jul 20174:30 pmRNSHolding(s) in Company
13th Jul 20174:02 pmRNSHolding(s) in Company
13th Jul 20179:25 amRNSHolding(s) in Company
13th Jul 20179:22 amRNSHolding(s) in Company
10th Jul 20177:00 amRNSDirectorate Change
10th Jul 20177:00 amRNSTrading Statement
6th Jul 20174:58 pmRNSHolding(s) in Company
30th Jun 201711:08 amRNSDirectorate Change
19th Jun 20179:07 amRNSBlock listing Interim Review
16th Jun 20174:25 pmRNSHolding(s) in Company
16th Jun 20174:21 pmRNSHolding(s) in Company
16th Jun 20172:26 pmRNSHolding(s) in Company
15th Jun 20177:20 amRNSHolding(s) in Company
14th Jun 20179:08 amRNSDirector/PDMR Shareholding
13th Jun 20174:53 pmRNSHolding(s) in Company
13th Jun 20172:20 pmRNSDirector/PDMR Shareholding
5th Jun 20172:50 pmRNSHolding(s) in Company
1st Jun 20174:25 pmRNSHolding(s) in Company
30th May 20178:07 amRNSHolding(s) in Company
22nd May 20172:38 pmRNSHolding(s) in Company
22nd May 201711:49 amRNSHolding(s) in Company
18th May 20173:25 pmRNSHolding(s) in Company
17th May 20172:15 pmRNSHolding(s) in Company
16th May 201711:47 amRNSHolding(s) in Company
10th May 20177:38 amRNSDirector/PDMR Shareholding
8th May 20173:53 pmRNSHolding(s) in Company
4th May 20172:32 pmRNSHolding(s) in Company
4th May 201710:55 amRNS2017 AGM Results
4th May 20178:29 amRNSHolding(s) in Company
3rd May 201711:57 amRNSAGM Statement
28th Apr 201712:53 pmRNSDirector Declaration
18th Apr 20179:09 amRNSHolding(s) in Company
18th Apr 20177:30 amRNSDirector/PDMR Shareholding
13th Apr 201711:19 amRNSHolding(s) in Company
12th Apr 20177:00 amRNSCarillion selected as preferred bidder
11th Apr 20174:19 pmRNSDirector/PDMR Shareholding
11th Apr 20174:13 pmRNSDirector/PDMR Shareholding
10th Apr 20177:00 amRNSCarillion JV awarded MoD contract
7th Apr 20174:14 pmRNSHolding(s) in Company
30th Mar 20178:07 amRNSHolding(s) in Company
29th Mar 20175:32 pmRNS2016 Annual Report & Accounts and 2017 AGM Notice
29th Mar 201712:37 pmRNSHolding(s) in Company
28th Mar 201712:25 pmRNSHolding(s) in Company
23rd Mar 20174:01 pmRNSHolding(s) in Company
20th Mar 20177:00 amRNSCarillion awarded £90m DIO contract in Cyprus
16th Mar 20178:28 amRNSHolding(s) in Company
16th Mar 20177:48 amRNSHolding(s) in Company
16th Mar 20177:46 amRNSHolding(s) in Company
14th Mar 20174:06 pmRNSHolding(s) in Company
3rd Mar 20179:25 amRNSJoint Venture awarded £490 million contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.